跳到正文
原文
Nature 健康护理主题·· 2026-10-19AI 评分54

0.01% 阿托品滴眼液用于近视控制的随机对照试验显示角膜 Biometry 变化及偶然发现的圆锥角膜病例

Corneal biometry changes with 0.01% atropine for myopia control: a randomised controlled trial and case of incidental keratoconus

AI 导读

0.01% 阿托品滴眼液在 153 名 6–16 岁进展性近视儿童中开展 2:1 随机对照试验,治疗 2 年并洗脱 1 年,通过 Scheimpflug 成像评估角膜参数。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Changes in corneal curvature have been reported with low-concentration atropine eyedrops for myopia treatment and have been suggested to play a role in the refractive changes observed during atropine therapy. A case of keratoconus was identified from the Western Australia atropine for the treatment of myopia (WA-ATOM) cohort. We tested the null hypothesis that 0.01% atropine eyedrops produce no change in corneal parameters or ectasia risk compared to placebo. Children with progressive myopia (6–16 years; n = 153) were randomly assigned to receive 0.01% atropine eyedrops or a placebo (2:1 ratio) for 2 years, followed by a 1-year washout. Scheimpflug imaging was performed at baseline, 24-months, and 36-months. Changes in corneal parameters were compared between the treatment and placebo groups using linear mixed models. One child allocated to the treatment group developed keratoconus during the treatment phase. At 24 and 36 months, the atropine group had significantly lower BAD-D values compared to placebo, with reductions of − 0.075 (95% CI  − 0.126 to − 0.023, p = 0.027) and − 0.115 (95% CI  − 0.168 to − 0.063, p = 0.005) from baseline, respectively (p = 0.029 and 0.005). At 36 months, a significant steepening of Kmax of + 0.301D (95% CI 0.214 to 0.389, p = 0.039) was observed in the atropine group. All other corneal parameters and cylindrical power remained similar between the groups. The case of incidental keratoconus in the treatment group (1 out of 153 children) is compatible with population prevalence rates. No signal suggesting a treatment-related increase in corneal ectatic changes was identified within the limitations of this cohort, and these findings provide reassurance from a safety perspective, but clinicians should be aware of the rare possibility of keratoconus and refer patients with suspicious corneal findings.

Funding

Telethon-Perth Children's Hospital Research Fund; University of Western Australia Research Collaboration Award; University of Western Australia Faculty of Health and Medical Sciences Early Career Researcher Small Grant Award; Australian Vision Research (formerly the Ophthalmic Research Institute of Australia). D.M. is funded by a Stan Perron Charitable Foundation People’s Grant. S.L. is supported by a Western Australian Future Health Research and Innovation Emerging Leaders Fellowship. The funding organisations had no role in the design or conduct of this research.

Author information

Authors and Affiliations

  1. Centre for Ophthalmology and Visual Science (Incorporating the Lions Eye Institute), University of Western Australia, 2 Verdun St, Nedlands, WA, 6009, Australia

    Alvid Soh, Gareth Lingham, Antony Clark, David A. Mackey & Samantha Sze-Yee Lee

  2. Sir Charles Gairdner and Osborne Park Health Care Group, Perth, WA, Australia

    Alvid Soh & Antony Clark

  3. Centre for Eye Research Ireland, Environmental, Sustainability and Health Institute, Technological University Dublin, Dublin, Ireland

    Gareth Lingham

  4. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Melbourne, VIC, Australia

    Gareth Lingham, Elsie Chan & David A. Mackey

  5. School of Medicine, Menzies Research Institute Tasmania, University of Tasmania, Hobart, TAS, Australia

    David A. Mackey

  6. QIMR Berghofer Medical Research Institute, Herston, QLD, Australia

    Samantha Sze-Yee Lee

Authors

  1. Alvid Soh
  2. Gareth Lingham
  3. Elsie Chan
  4. Antony Clark
  5. David A. Mackey
  6. Samantha Sze-Yee Lee

Corresponding author

Correspondence to Samantha Sze-Yee Lee.

Ethics declarations

Competing interests

G.L. and A.C. are employed by Ocumetra. D.M. consults for PYC Therapeutics and holds leadership positions in the Australian Academy of Health and Medical Science, the Asia Pacific Academy of Ophthalmology, and the Royal Australian and New Zealand College of Ophthalmologists. A.S., E.C., and S.L. declare no potential conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soh, A., Lingham, G., Chan, E. et al. Corneal biometry changes with 0.01% atropine for myopia control: a randomised controlled trial and case of incidental keratoconus. Sci Rep (2026). https://doi.org/10.1038/s41598-026-74892-8

Download citation

  • Received: 05 August 2026

  • Accepted: 01 October 2026

  • Published: 19 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-74892-8

Keywords

来源:Nature 健康护理主题 · nature.com